(1) Results: Hydrosalpinx fluid significantly decreased the hatching rate of blastocysts and the concentrations of MMP-9 and TIMP-1 both in blastocysts and culture medium, in a dose dependent manner.

(2) Objective: To study effect of hydrosalpinx fluid on mouse early embryos development in vitro.

(3) Objective: To evaluate the effect of hydrosalpinx on in vitro fertilization and embryo transfer (IVF - ET).

(4) If hydrosalpinx or oviduct ovarian cyst, criterion in pelvic one or both cystic neoplasm touch, activities more limited.

(5) Some women with hydrosalpinx may have constant or frequent pain in their lower or abdomen.

(6) Conclusion: Hydrosalpinx fluid might interfere with the blastocyst implantation by decreasing the MMP-9/TIMP-1 secretion and impairing the early development of blastocysts.

(7) Conclusions Hydrosalpinx is associated with poor IVF-ET outcomes. Laparoscopic management for hydrosalpinx prior to IVF-ET improves the pregnancy rate of IVF-ET.

(8) To evaluate the effect of treatment for hydrosalpinx on in vitro fertilization-embryo transfer(IVF-ET).

(9) Conclusion: Hydrosalpinx fluid may affect the ability of mouse early embryo development in vitro.

(10) Chronic accessory phlogistic if there are cured the hydrosalpinx or ovarian cyst, also want to surgery.

(11) Objective: To explore the effect of hydrosalpinx fluid (HSF) on human early embryo development in vitro.

(12) Methods The rabbit hydrosalpinx model was developed by ligation of oviduct at the uterotubal junction.

(13) It is very important to refer the clinical results for diagnosing the hydrosalpinx or pyosalpinx correctly with CT .

(14) There was no significant difference in morula development when cloned embryos cultured in 20% hydrosalpinx fluid media (7.3%) compared with those cultured in vivo (11.1%).

(15) Objective To evaluate effects of different laparoscopic procedures for hydrosalpinx on ovarian responses to superovulation induction during in vitro fertilization-embryo transfer(IVF-ET).